does tirzepatide cause blindness Comparative ocular outcomes of versus other anti-obesity medications in people with obesity Vision loss risks in patients

, , , , , GLP-1R ,

Warning labels on Mounjaro, Ozempic, and a whole host of other similar type 2 diabetes drugs list gastrointestinal problems, such as the following, as potential side effects associated with them: Abdominal discomfort or pain Nausea Bloating Vomiting Constipation Discolored stools Indigestion Diarrhea However, in entering Ozempic, Mounjaro, and other similar medications into the FDA Adverse Events Reporting System (FAERS) Public Dashboard, thousands of reports of much more serious adverse side effects, including the following, come up: Pancreatitis Gallbladder issues Kidney failure Thyroid tumors Cancer Gastroparesis Gastroparesis, also known as stomach paralysis, is what has led to many patients filing lawsuits against the drugs manufacturers most recently

Biopsy #2 for all three patients was obtained at the time of enrollment into the NAC clinical trial (EudraCT#: 2017-004776-56), at which time carrier 1 had taken 600 mg of NAC 3 per day for over 24 months and carrier 2 for approximately 8 months

Diabetes and Metabolism Reviews, 15(2), 120-132